[111In]-FPI-2107
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [111In]-FPI-2107, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC [Phase 1]